Biotechnology News

Wed, 2015-11-11 13:00

WASHINGTON--(BUSINESS WIRE)--BIO today thanked Senators Stabenow (D-MI), Coons (D-DE) and Franken (D-MN) for introducing S. 2271, the Renewable Chemicals Act of 2015.

Wed, 2015-11-11 13:00

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research, an Altasciences Clinical Research company, is a leading provider of comprehensive, early development clinical research services for the global biopharmaceutical...

Wed, 2015-11-11 13:00

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Foundation Awards Five Grants Totaling More than $2.77M to Programs Supporting Post-9/11 Military Veterans, their Families and Caregivers

Wed, 2015-11-11 12:00

CAMBRIDGE, Mass. & PARSIPPANY, N.J.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, and The Medicines Company (Nasdaq:MDCO), a leading biopharmaceutical development and cardiovascular...

Wed, 2015-11-11 12:00

BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc., announced positive findings for its ARC002 clinical trial, a follow-on Phase 2 study of the company’s lead product candidate, AR101 for the treatment of peanut allergy.

Wed, 2015-11-11 12:00

ANDOVER, Mass.--(BUSINESS WIRE)--In preclinical experiments, DeuteRx demonstrated that DRX-065 has pharmacological properties desirable for the treatment of NASH.

Wed, 2015-11-11 12:00

WILMINGTON, N.C.--(BUSINESS WIRE)--X-Rx, Inc. announced today that it has entered into an exclusive agreement with Gilead Sciences, Inc. to develop X-Rx’s proprietary small molecule autotaxin (ATX) inhibitors. ATX plays a key role in maintaining...

Wed, 2015-11-11 12:00

CARDIFF, Wales--(BUSINESS WIRE)--TrakCel Ltd., a pioneer in cell therapy process management and supply chain integration technology today introduces Cognate BioServices as the newest member of the Connected Service programme.

Wed, 2015-11-11 12:00

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Protalex, Inc. (OTCQB:PRTX), a clinical-stage biopharmaceutical company, today announced that an abstract highlighting preclinical results from a study of Staphylococcal protein A (PRTX-100) for the treatment...

Wed, 2015-11-11 12:00

WALTHAM, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Inc. Announces Removal of Partial Clinical Hold on Phase 3 Encenicline Program for Cognitive Impairment in Schizophrenia

Wed, 2015-11-11 12:00

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics announced today that CEO Gary Maharaj and CFO Andy LaFrence will make a presentation at the Canaccord Genuity Medical Technology and Diagnostics Forum in New York City on November 19.

Wed, 2015-11-11 09:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Chip Clark, president and chief executive officer, will present...

Wed, 2015-11-11 09:01

LAKE FOREST, Calif.--(BUSINESS WIRE)--Cryoport, Inc. is pleased to announce that Mark Sawicki, Ph.D., CCO, will speak alongside Robin Hooker, healthcare marketing director for UPS, at the CAR-T Summit in Boston at 3:30 p.m. Nov. 13, 2015.

Wed, 2015-11-11 09:01

BARCELONA, Spain--(BUSINESS WIRE)--AXON Neuroscience presented encouraging Phase 1 study results of its active tau vaccine AADvac1 and exceptional pre-clinical results of the company's passive tau vaccine AADvac2 at CTAD 2015.

Wed, 2015-11-11 09:01

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at upcoming conferences

Wed, 2015-11-11 09:01

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals will hold its third quarter 2015 investment community conference call on November 16 at 8:30 a.m. ET

Wed, 2015-11-11 09:01

HAMBURG, Germany--(BUSINESS WIRE)--Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its CEO, Dr Werner Lanthaler, will present at the Jefferies 2015 Global Healthcare Conference in London, UK, and at the...

Wed, 2015-11-11 09:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--WAVE Life Sciences Ltd. (NASDAQ: WVE), a preclinical biopharmaceutical company, today announced the pricing of its initial public offering.

Wed, 2015-11-11 07:00

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE:HTGC) (“Hercules”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced...

Wed, 2015-11-11 07:00

INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim is launching a new research and development (R&D) strategy and a five-year R&D investment programme. This new plan was announced today at its R&D press conference in Berlin....

Wed, 2015-11-11 07:00

LONDON--(BUSINESS WIRE)--Laser-emitting shoes and a Meccano-style walking aid kit are just two of the inventions being developed by companies in and the south east that could help people stay independent for longer as they get older or develop...

Wed, 2015-11-11 05:00

GENEVA & ARCHAMPS, France--(BUSINESS WIRE)--Genkyotex's GKT137831, its lead NOX1&4 inhibitor, was granted Orphan Drug designation for the treatment of systemic sclerosis in the US and EU.

Wed, 2015-11-11 05:00

BRUSSELS--(BUSINESS WIRE)--UVLrx Therapeutics™ is pleased to present its intravenous light treatment system at the 5th Annual Pro-Aging Europe Congress in Brussels, Belgium from November 19 to 22.

Tue, 2015-11-10 20:02

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--More than $4.5 million was raised at CSHL's 10th Double Helix Medals dinner. The gala, held at the American Museum of Natural History, honored Katie Couric, Anne Wojcicki and David Botstein.

Tue, 2015-11-10 18:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM) (“Enumeral” or the “Company”), a biotechnology company focused on discovering and developing novel antibody immunotherapies that help the immune system fight...

Tue, 2015-11-10 18:01

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2015 and provided an update on progress toward delivering upon its key 2015 corporate objectives and clinical...

Tue, 2015-11-10 18:01

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial...

Tue, 2015-11-10 18:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNA interference-based investigational therapeutics targeting rare inherited diseases involving the liver and for cancers that are...

Tue, 2015-11-10 18:01

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa today announced results of a preclinical study, which show that T-cell immunotherapy with attenuated antigen-specific T-cells suppress the T-cell response to Aquaporin-4 (AQP4).

Tue, 2015-11-10 18:01

SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today reported business highlights and financial results for...

Tue, 2015-11-10 18:01

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of...

Tue, 2015-11-10 18:01

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa today reported financial results for the three months ended September 30, 2015 and provided an update on the Company’s recent corporate developments.

Tue, 2015-11-10 18:01

BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (NASDAQ: FLKS): Click to Tweet this News Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg...

Tue, 2015-11-10 18:01

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) Gene Cassis, Chief Financial Officer, will speak to the investment community at the Stifel 2015 Healthcare Conference at the New York Palace Hotel in New York on Tuesday, November 17...

Tue, 2015-11-10 16:00

LOS ANGELES--(BUSINESS WIRE)--AHF: Gilead's "New Drug" Genvoya is a Dodge to Extend Patent/Profits

Tue, 2015-11-10 16:00

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Stifel Healthcare Conference in New York City on November 17, 2015. John H. Weiland, president and chief operating officer, will discuss...

Tue, 2015-11-10 16:00

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) approved Cotellic™ (cobimetinib) for the treatment of people with...

Tue, 2015-11-10 14:01

NASHVILLE, Tenn.--(BUSINESS WIRE)--Insight Genetics, Inc. today announced that Ronald (Ronnie) Andrews Jr., former president of the Genetic Science Division of Thermo Fisher Scientific, has been named to the company’s Board of Directors. Andrews...

Tue, 2015-11-10 14:01

ALISO VIEJO, Calif.--(BUSINESS WIRE)--The Mauli Ola Foundation today announced that professional surfer Coco Ho is the winner of its second annual Battle For The Breasts.

Tue, 2015-11-10 14:01

PHILADELPHIA--(BUSINESS WIRE)--Philadelphia-based National Disease Research Interchange (NDRI), the nation’s premier provider of human biospecimens to advance medical disease research, announces the election of Mary J.C. Hendrix, PhD, as Chair of...

Tue, 2015-11-10 14:01

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Circulogene Theranostics launches cell-free DNA liquid biopsy products, becomes first and only biotechnology company able to enrich circulating cfDNA from a single blood drop for cancer monitoring.

Tue, 2015-11-10 14:01

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced results of a sub-analysis of the PEGASUS-TIMI 54 study, which evaluated reasons and rates for discontinuation of BRILINTA® (ticagrelor) in patients with a history of...

Tue, 2015-11-10 12:01

WASHINGTON--(BUSINESS WIRE)--NJ Gov. Christie signed important legislation to create a pathway for the substitution of interchangeable biologic medicines.

Tue, 2015-11-10 12:01

SAN DIEGO--(BUSINESS WIRE)--NeuroGenetic Pharmaceuticals awarded $2.5 Million grant from NIA to conduct clinical trails with NGP 555 to treat and prevent Alzheimer’s disease.

Tue, 2015-11-10 12:01

ANN ARBOR, Mich.--(BUSINESS WIRE)--Gene Codes Corporation has announced the release of Sequencher 5.4, DNA Sequence Analysis Software. Sequencher 5.4 continues Gene Codes’ mission of empowering the bench scientist with the latest bioinformatics...